Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Graeber

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Cancer Cell|May 31, 2011
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growthDavid J Mulholland, Linh M Tran, Yunfeng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cellsDiego Ploper, Vincent F Taelman, Lidia Robert, et al.
The Prostate|April 25, 2003
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor systemStephen J Freedland, Allan J Pantuck, Sun H Paik, et al.
Cancer|November 26, 1999
A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusionsJ B Putnam, R W Light, R M Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Effects of MAPK and PI3K pathways on PD-L1 expression in melanomaMohammad Atefi, Earl Avramis, Amanda Lassen, et al.
Cancer Research|June 14, 2012
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapyRichard C Koya, Stephen Mok, Nicholas Otte, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Science Translational Medicine|March 20, 2015
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanomaSiwen Hu-Lieskovan, Stephen Mok, Blanca Homet Moreno, et al.
Cell Reports|September 21, 2018
A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial CancersBryan A Smith, Nikolas G Balanis, Avinash Nanjundiah, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targetsJustin M Drake, Nicholas A Graham, John K Lee, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Cancer Cell|May 31, 2011
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growthDavid J Mulholland, Linh M Tran, Yunfeng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cellsDiego Ploper, Vincent F Taelman, Lidia Robert, et al.
The Prostate|April 25, 2003
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor systemStephen J Freedland, Allan J Pantuck, Sun H Paik, et al.
Cancer|November 26, 1999
A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusionsJ B Putnam, R W Light, R M Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Effects of MAPK and PI3K pathways on PD-L1 expression in melanomaMohammad Atefi, Earl Avramis, Amanda Lassen, et al.
Cancer Research|June 14, 2012
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapyRichard C Koya, Stephen Mok, Nicholas Otte, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Science Translational Medicine|March 20, 2015
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanomaSiwen Hu-Lieskovan, Stephen Mok, Blanca Homet Moreno, et al.
Cell Reports|September 21, 2018
A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial CancersBryan A Smith, Nikolas G Balanis, Avinash Nanjundiah, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targetsJustin M Drake, Nicholas A Graham, John K Lee, et al.
Pageof 16